Topical Antibiotic-Steroid — Otitis Externa
Pregnancy: Topical use — use with caution; avoid prolonged courses; safe for short-term acute otitis externa
Framycetin / Sofradex
Brand names: Sofradex (framycetin + dexamethasone + gramicidin)
Adult dose
Dose: 2–3 drops
Route: Otic
Frequency: Three to four times daily for up to 7 days
Max: 3 drops per ear four times daily
Combination topical preparation: framycetin (aminoglycoside antibacterial) + gramicidin (antibacterial) + dexamethasone 0.1% (anti-inflammatory). Used for acute otitis externa with significant inflammation. CONTRAINDICATED with perforated tympanic membrane — aminoglycoside ototoxicity. Also licensed as eye drops for conjunctivitis.
Paediatric dose
Dose: 2–3 drops drops/kg
Route: Otic
Frequency: Three times daily
Max: 3 drops per ear three times daily
BNFc: avoid prolonged use in children; CONTRAINDICATED with perforated TM. Review after 7 days.
Dose adjustments
Renal
No dose adjustment required (topical)
Hepatic
No dose adjustment required
Paediatric weight-based calculator
BNFc: avoid prolonged use in children; CONTRAINDICATED with perforated TM. Review after 7 days.
Clinical pearls
- Framycetin is an aminoglycoside antibiotic — same ototoxicity risk as neomycin and gentamicin with perforated TM; NEVER use with perforation
- Sofradex is dual-purpose (ear and eye) — same formulation used for otitis externa and bacterial conjunctivitis; verify indication before prescribing
- Contact sensitisation: framycetin cross-reacts with neomycin — patients sensitised to neomycin (Otosporin) will also react to Sofradex
- Dexamethasone component reduces canal oedema, which is often as important as treating infection in OE
- Duration: limit to 7 days — prolonged aminoglycoside use increases sensitisation and risk; review and switch to alternative if extending course
- If TM status uncertain: use acetic acid drops (EarCalm) or ciprofloxacin ear drops (Ciloxan) — safe with perforation
Contraindications
- Perforated tympanic membrane — CONTRAINDICATED (framycetin is aminoglycoside — ototoxic)
- Fungal or viral otitis externa
- Hypersensitivity to framycetin or neomycin (cross-reactivity)
Side effects
- Aminoglycoside ototoxicity (with perforated TM)
- Contact sensitisation to framycetin (neomycin cross-reactive)
- Local irritation
- Adrenal suppression (prolonged use — dexamethasone component)
Interactions
- Negligible at topical otic doses
Monitoring
- Symptom response at 7 days
- TM integrity before prescribing
- Signs of sensitisation
Reference: BNFc; BNF 90; BNFc; ENT-UK Otitis Externa Guidelines; NICE CKS Otitis Externa. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Steroid Dose Equivalence · Medications
- Adrenal Crisis Risk Score · Adrenal Disorders
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Acute Otitis Media Severity (AOM-SOS) · Otitis Media
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020